Literature DB >> 11382916

The relationship between esophageal pressure and apnea hypopnea index in obstructive sleep apnea-hypopnea syndrome.

T Watanabe1, T Kumano-Go, N Suganuma, Y Shigedo, M Motonishi, H Honda, K Kyotani, S Uruha, K Terashima, Y Teshima, M Takeda, Y Sugita.   

Abstract

Severity of negative esophageal pressure (Pes) and apnea hypopnea index (AHI) were investigated in 34 patients with obstructive sleep apnea-hypopnea syndrome (OSAHS). The OSAHS patients were diagnostically classified as having obstructive sleep apnea syndrome (OSAS) or upper airway resistance syndrome (UARS). Diagnosis of OSAS was based on an AHI of more than 5, and that of UARS on an AHI of less than 5, EEG arousals which were associated with apnea, hypopnea and/or respiratory effort occurring more than 10 times per hour, and daytime sleepiness. Negative Pes was represented by the greatest peak (NPes Max) and the number of increased (more than 13.5 cmH2O) episodes per hour (NPesI13.5). There was no significant correlation between the AHI and Pes indices, but NPes Max and NPesI13.5 showed significant correlation (p<0.01). NPes Max and NPesI13.5 showed no significant differences among the severe OSAS (AHI>50; 8 cases), moderate OSAS (50>AHI>15; 10 cases), mild OSAS (15>AHI>5; 9 cases) and UARS (7 cases) groups. We conclude that AHI does not reflect the severity of the increase in negative Pes, which is an important aspect of the pathophysiology of OSAHS. Assessment of OSAHS based on AHI alone may therefore underestimate the risk of increased negative Pes in cases with reduced AHI.

Entities:  

Mesh:

Year:  2000        PMID: 11382916

Source DB:  PubMed          Journal:  Sleep Res Online        ISSN: 1096-214X


  3 in total

1.  Increased respiratory effort during sleep is non-invasively detected with movement sensor.

Authors:  Mirja Tenhunen; Esa Rauhala; Jussi Virkkala; Olli Polo; Antti Saastamoinen; Sari-Leena Himanen
Journal:  Sleep Breath       Date:  2010-10-20       Impact factor: 2.816

2.  Pneumothorax as an initial manifestation of obstructive sleep apnea syndrome.

Authors:  Baykal Tulek; Fikret Kanat; Sebnem Yosunkaya; Sami Ceran; Mecit Suerdem
Journal:  Sleep Breath       Date:  2009-11-07       Impact factor: 2.816

3.  Patients with obstructive sleep apnea have suppressed levels of soluble cytokine receptors involved in neurodegenerative disease, but normal levels with airways therapy.

Authors:  Ye Wang; Richard B Meagher; Suresh Ambati; Ping Ma; Bradley G Phillips
Journal:  Sleep Breath       Date:  2020-10-09       Impact factor: 2.816

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.